ArticlebioRxiv : the preprint server for biology2026
Atto 643 Carboxy Selectively Labels Astrocytes with Minimal Oligodendrocyte Cross-Reactivity.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Astrocytes are critical regulators of brain homeostasis and circuit function, and sulforhodamine 101 (SR101) are widely used for astrocyte labeling. However, SR101 also labels a significant portion of oligodendrocytes. Here, we identified Atto 643 carboxy, a far-red fluorescent dye, as a highly specific marker for astrocytes with minimal oligodendrocyte labeling. Furthermore, Atto 643 carboxy demonstrates minimal nonspecific uptake in myelin sheaths, and hippocampal pyramidal neuron as reported for SR101. We demonstrate robust imaging of astrocyte morphology and distribution in vivo and in acute brain slices. Our findings establish Atto 643 carboxy as a highly specific small-molecule probe for astrocyte-selective imaging, offering a powerful tool for dissecting astrocyte structure, dynamics, and function in intact brain tissue.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.